We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

U.K. CELL AND GENE THERAPY RESEARCH CHALLENGES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2021 - 2028)

U.K. Cell and Gene Therapy Research Challenges Market, by Therapy Type (Cell Therapy (Stem Cells, T Cells, Dendritic Cells, and NK Cells) and Gene Therapy (Germline Gene Therapy and Somatic Gene Therapy)), and by Indication (Dermatology, Musculoskeletal, Oncology, Immunology, Cardiology & Neurology, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In: 28 Jan, 2022
Code: CMI4889
Page number: 140
Formats: Excel and PDF
Industry: Biotechnology

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Therapy Type
  - Market Snippet, By Indication
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Partnership and Collaboration Scenario
- Approved Gene Therapies
- Pipeline Analysis
- PEST Analysis
- PORTER’S Five Forces
- Epidemiology
U.K. Cell and Gene Therapy Research Challenges Market – Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- Impact on Clinical Trials and Drug Development
- Government Initiatives
U.K. Cell and Gene Therapy Research Challenges Market, By Therapy Type, 2021 – 2028, (US$ Mn.)
- Introduction
  - Market Share Analysis, 2021 and 2028 (%)
  - Y-o-Y Growth Analysis, 2018 – 2028
  - Segment Trends
- Cell Therapy
  - Stem Cells
    - Introduction
    - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
  - T Cells
    - Introduction
    - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
  - Dendritic Cells
    - Introduction
    - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
  - NK Cells
    - Introduction
    - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
- Gene Therapy
  - Germline Gene Therapy
    - Introduction
    - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
  - Somatic Gene Therapy
    - Introduction
    - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
U.K. Cell and Gene Therapy Research Challenges Market, By Indication, 2021 – 2028, (US$ Mn.)
- Introduction
  - Market Share Analysis, 2021 and 2028 (%)
  - Y-o-Y Growth Analysis, 2018 – 2028
  - Segment Trends
- Dermatology
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
- Musculoskeletal
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
- Oncology
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
- Immunology
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
- Cardiology & Neurology
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn.)
Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
  - Novartis International AG*
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Pfizer, Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Sanofi S.A.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Amgen, Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - PTC Therapeutics, Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Orchard Therapeutics Plc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Biomarin Pharmaceutical Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Regeneron
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Bluebird Bio, Inc. (Celgene Corporation)
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Freeline Therapeutics Ltd
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - MeiraGTx Limited
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Kolon TissueGene, Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Kite Pharma, Inc. (Gilead Sciences, Inc.)
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Biogen INC
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Bristol-Myers Squibb Company
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
- Analyst Views
Section
- References
- Research Methodology
- About Us and Sales Contact

*Browse 12 market data tables and 18 figures on "Cell and Gene Therapy Research Challenges Market” – U.K. forecast to 2028

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now